326
Views
2
CrossRef citations to date
0
Altmetric
Review

Transcranial magnetic stimulation to monitor disease progression in ALS: a review

ORCID Icon &
Pages 362-368 | Received 21 Sep 2022, Accepted 05 Dec 2022, Published online: 27 Dec 2022

References

  • Rossini PM, Rossi S. Transcranial magnetic stimulation: diagnostic, therapeutic, and research potential. Neurology 2007;68:484–8.
  • Kojovic M, Kassavetis P, Bologna M, Pareés I, Rubio‐Agusti I, Beraredelli A, et al. Transcranial magnetic stimulation follow‐up study in early Parkinson’s disease: a decline in compensation with disease progression? Mov Disord. 2015;30:1098–106.
  • Fierro B, Salemi G, Brighina F, Buffa D, Conte S, Bua VL, et al. A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis. Acta Neurol Scand. 2002;105:152–7.
  • Eisen A, Kim S, Pant B. Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron? Muscle Nerve. 1992;15:219–24.
  • Pamphlett R, Kril J, Hng TM. Motor neuron disease: a primary disorder of corticomotoneurons? Muscle Nerve. 1995;18:314–8.
  • Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 2009;73:805–11.
  • Chand KK, Lee KM, Lee JD, Qiu H, Willis EF, Lavidis NA, et al. Defects in synaptic transmission at the neuromuscular junction precede motor deficits in a TDP‐43Q331K transgenic mouse model of amyotrophic lateral sclerosis. Faseb J. 2018;32:2676–89.
  • Swash M, Burke D, Turner MR, Grosskreutz J, Leigh PN, deCarvalho M, et al. Occasional essay: upper motor neuron syndrome in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2020;91:227–34.
  • Vucic S, Pavey N, Haidar M, Turner BJ, Kiernan MC. Cortical hyperexcitability: Diagnostic and pathogenic biomarker of ALS. Neurosci Lett. 2021;759:136039.
  • Clark R, Blizzard C, Dickson T. Inhibitory dysfunction in amyotrophic lateral sclerosis: future therapeutic opportunities. Neurodegener Dis Manag. 2015; 5:511–25.
  • Desiato MT, Caramia MD. Towards a neurophysiological marker of amyotrophic lateral sclerosis as revealed by changes in cortical excitability: Distinguishing characteristics of amyotrophic lateral sclerosis by using cortical stimulation. Electroencephalogr Clin Neurophysiol.1997;105:1–7.
  • Eisen A, Pant B, Stewart H. Cortical excitability in amyotrophic lateral sclerosis: a clue to pathogenesis. Can J Neurol Sci. 1993;20:11–6.
  • de Carvalho M, Turkman A, Swash M. Motor responses evoked by transcranial magnetic stimulation and peripheral nerve stimulation in the ulnar innervation in amyotrophic lateral sclerosis: the effect of upper and lower motor neuron lesion. J Neurol Sci. 2003;210:83–90.
  • Nakajima M, Eisen A, McCarthy R, Olney RK, Aminoff MJ. Reduced corticomotoneuronal excitatory postsynaptic potentials (EPSPs) with normal Ia afferent EPSPs in amyotrophic lateral sclerosis. Neurology 1996;47:1555–61.
  • de Carvalho M, Kiernan MC, Pullman SL, Rezania K, Turner MR, Simmons Z, et al. Neurophysiological features of primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:11–7.
  • Zanette G, Tamburin S, Manganotti P, Refatti N, Forgione A, Rizzuto N. Changes in motor cortex inhibition over time in patients with amyotrophic lateral sclerosis. J Neurol. 2002;249:1723–8.
  • Mills KR. The natural history of central motor abnormalities in amyotrophic lateral sclerosis. Brain. 2003;126:2558–66.
  • Floyd AG, Yu QP, Piboolnurak P, Tang MX, Fang Y, Smith WA, et al. Transcranial magnetic stimulation in ALS: utility of central motor conduction tests. Neurology 2009;72:498–504.
  • de Carvalho M, Swash M. Sensitivity of electrophysiological tests for upper and lower motor neuron dysfunction in ALS: A six‐month longitudinal study. Muscle Nerve 2010;41:208–11.
  • Sasaki S, Iwata M. Ultrastructural change of synapses of Betz cells in patients with amyotrophic lateral sclerosis. Neurosci Lett. 1999;268:29–32.
  • Mills KR, Nithi KA. Peripheral and central motor conduction in amyotrophic lateral sclerosis. J Neurol Sci. 1998;159:82–7.
  • Menon P, Higashihara M, van den Bos M, Geevasinga N, Kiernan MC, Vucic S. Cortical hyperexcitability evolves with disease progression in ALS. Ann Clin Transl Neurol. 2020;7:733–41.
  • Triggs WJ, Menkes D, Onorato J, Yan RH, Young MS, Newell K, et al. Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease. Neurology 1999;53:605–11.
  • Claus D, Brunhölzl C, Kerling FP, Henschel S. Transcranial magnetic stimulation as a diagnostic and prognostic test in amyotrophic lateral sclerosis. J Neurol Sci.1995;129:30–4.
  • Magistris MR, Rösler KM, Truffert A, Myers JP. Transcranial stimulation excites virtually all motor neurons supplying the target muscle. A demonstration and a method improving the study of motor evoked potentials. Brain.1998;121:437–50.
  • Rösler KM, Truffert A, Hess CW, Magistris MR. Quantification of upper motor neuron loss in amyotrophic lateral sclerosis. Clin Neurophysiol. 2000;111:2208–18.
  • Grapperon AM, Verschueren A, Jouve E, Morizot-Koutlidis R, Lenglet T, Pradat PF, et al. Assessing the upper motor neuron in amyotrophic lateral sclerosis using the triple stimulation technique: A multicenter prospective study. Clin Neurophysiol. 2021;132:2551–7.
  • Boniface SJ, Mills KR, Schubert M. Responses of single spinal motoneurons to magnetic brain stimulation in healthy subjects and patients with multiple sclerosis. Brain 1991;114:643–62.
  • Weber M, Eisen A. Peristimulus time histograms (PSTHs)–a marker for upper motor neuron involvement in ALS? Amyotroph Lateral Scler Other Motor Neuron Disord.2000;1:S51–S56.
  • Awiszus F, Feistner H. Abnormal EPSPs evoked by magnetic brain stimulation in hand muscle motoneurons of patients with amyotrophic lateral sclerosis. Electroencephalogr Clin Neurophysiol. 1993;89:408–14.
  • Mills KR. Motor neuron disease: studies of the corticospinal excitation of single motor neurons by magnetic brain stimulation. Brain 1995;118:971–82.
  • Eisen A, Entezari-Taher M, Stewart H. Cortical projections to spinal motoneurons: changes with aging and amyotrophic lateral sclerosis. Neurology 1996;46:1396–404.
  • Weber M, Eisen A, Nakajima M. Corticomotoneuronal activity in ALS: changes in the peristimulus time histogram over time. Clin Neurophysiol. 2000;111:169–77.
  • Attarian S, Pouget J, Schmied A. Changes in cortically induced inhibition in amyotrophic lateral sclerosis with time. Muscle Nerve. 2009;39:310–7.
  • Prout AJ, Eisen AA. The cortical silent period and amyotrophic lateral sclerosis. Muscle Nerve. 1994;17:217–23.
  • Siciliano G, Manca ML, Sagliocco L, Pastorini E, Pellegrinetti A, Sartucci F, et al. Cortical silent period in patients with amyotrophic lateral sclerosis. J Neurol Sci. 1999;169:93–7.
  • Yokota T, Yoshino A, Inaba A, Saito Y. Double cortical stimulation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1996;61:596–600.
  • Ferrer I, Tuñón T, Serrano MT, Casas R, Alcantara S, Zujar MJ, et al. Calbindin D-28k and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non-Alzheimer type associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1993;56:257–61.
  • Stagg CJ, Bestmann S, Constantinescu AO, Moreno Moreno L, Allman C, Mekle R, et al. Relationship between physiological measures of excitability and levels of glutamate and GABA in the human motor cortex. J Physiol. 2011; 589:5845–55.
  • Fisher RJ, Nakamura Y, Bestmann S, Rothwell JC, Bostock H. Two phases of intracortical inhibition revealed by transcranial magnetic threshold tracking. Exp Brain Res. 2002;143:240–8.
  • Awiszus F, Feistner H, Urbach D, Bostock H. Characterisation of paired-pulse transcranial magnetic stimulation conditions yielding intracortical inhibition or I-wave facilitation using a threshold-hunting paradigm. Exp Brain Res. 1999; 129:317–24.
  • Ziemann U, Winter M, Reimers CD, Reimers K, Tergau F, Paulus W. Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis: evidence from paired transcranial magnetic stimulation. Neurology 1997;49:1292–8.
  • Vucic S, Kiernan MC. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain. 2006;129:2436–46.
  • Tankisi H, Cengiz B, Howells J, Samusyte G, Koltzenburg M, Bostock H. Short-interval intracortical inhibition as a function of inter-stimulus interval: three methods compared. Brain Stimul. 2021;14:22–32.
  • Menon P, Geevasinga N, Yiannikas C, Howells J, Kiernan MC, Vucic S. Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study. Lancet Neurol. 2015;14:478–84.
  • Tankisi H, Nielsen CS, Howells J, Cengiz B, Samusyte G, Koltzenburg M, et al. Early diagnosis of amyotrophic lateral sclerosis by threshold tracking and conventional transcranial magnetic stimulation. Eur J Neurol. 2021;28:3030–9.
  • Vucic S, Nicholson GA, Kiernan MC. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain. 2008;131:1540–50.
  • Shibuya K, Park SB, Geevasinga N, Menon P, Howells J, Simon NG, et al. Motor cortical function determines prognosis in sporadic ALS. Neurology 2016;87:513–20.
  • Suzuki YI, Shibuya K, Misawa S, Suichi T, Tsuneyama A, Kojima Y, et al. Relationship between motor cortical and peripheral axonal hyperexcitability in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2022;93:1074–9.
  • Shibuya K, Simon NG, Geevasinga N, Menon P, Howells J, Park SB, et al. The evolution of motor cortical dysfunction in amyotrophic lateral sclerosis. Clin Neurophysiol. 2017;128:1075–82.
  • Miranda PC, de Carvalho M, Conceição I, Luis MS, Ducla-Soares E. A new method for reproducible coil positioning in transcranial magnetic stimulation mapping. Electroencephalogr Clin Neurophysiol 1997;105:116–23.
  • Triggs WJ, Subramanium B, Rossi F. Hand preference and transcranial magnetic stimulation asymmetry of cortical motor representation. Brain Res. 1999;835:324–9.
  • Kew JJ, Ridding MC, Rothwell JC, Passingham RE, Leigh PN, Sooriakumaran S, et al. Reorganization of cortical blood flow and transcranial magnetic stimulation maps in human subjects after upper limb amputation. J Neurophysiol. 1994;72:2517–24.
  • de Carvalho M, Miranda PC, Lu⏧s MLS, Ducla-Soares E. Cortical muscle representation in amyotrophic lateral sclerosis patients: changes with disease evolution. Muscle Nerve. 1999;22:1684–92.
  • Chervyakov AV, Bakulin IS, Savitskaya NG, Arkhipov IV, Gavrilov AV, Zakharova MN, et al. Navigated transcranial magnetic stimulation in amyotrophic lateral sclerosis. Muscle Nerve. 2015;51:125–31.
  • Van Eijk RP, Westeneng HJ, Nikolakopoulos S, Verhagen IE, Van Es MA, Eijkemans MJ, et al. Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials. Neurology 2019;92:e451-60–e460.
  • de Carvalho M, Swash M. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis? Arch Neurol. 2006;63:557–60.
  • Kimiskidis VK, Papagiannopoulos S, Sotirakoglou K, Kazis DA, Dimopoulos G, Kazis A, et al. The repeatability of corticomotor threshold measurements. Neurophysiol Clin. 2004;34:259–66.
  • Mills KR, Nithi KA. Corticomotor threshold to magnetic stimulation: normal values and repeatability. Muscle Nerve. 1997;20:570–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.